Describe the Effect of the Optimized Hemodialysis Technique (HDx) With Medium Cut-Off Membrane on Recovery Time and Quality of Life — EHDXTRQV  

Terminal Renal Insufficiency Clinical Trial

Official title: Pilot Study: Describe the Effect of the Optimized Hemodialysis Technique (HDx) With Medium Cut-Off Membrane on Recovery Time and Quality of Life

Status Recruiting

Clinical Trial Summary

In this study, the effect of optimizing the dialytic technique using simple questionnaires carried out in clinical routine will be described.

More specifically, the conventional dialysis technique will be combined with biofeedback software called HemoControl™. The recovery time and quality of life of patients who will use a polyethersulfone membrane (Revaclear®) and a Medium Cut-Off (MCO) membrane (Theranova®) will be observed.

The main objective is to describe the evolution of recovery time after a dialysis session in conventional hemodialysis (HD) on Revaclear® membrane and in so-called optimized hemodialysis (HDx) on MCO membrane, Theranova®.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Renal Insufficiency
• Terminal Renal Insufficiency

• NCT number: NCT05689801
• Study type: Interventional
• Source: Ramsay Générale de Santé
• Contact: Guy Rostoker, Dr
• Phone: 01 69 39 92 00
• Email: rostotom@orange.fr
• Status: Recruiting
• Phase: N/A
• Start date: December 15, 2022
• Completion date: January 15, 2024